<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Neurosurgery</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/02904723-E7E3-4F86-89FE-0CA15D44C46A"><gtr:id>02904723-E7E3-4F86-89FE-0CA15D44C46A</gtr:id><gtr:firstName>Adel</gtr:firstName><gtr:otherNames>Ezzat</gtr:otherNames><gtr:surname>Helmy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802251"><gtr:id>82E5D4F6-F0CB-4419-80E9-8B80B2EC3338</gtr:id><gtr:title>Neuro-inflammation following Human Traumatic Brain Injury</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802251</gtr:grantReference><gtr:abstractText>Head injury is an important health issue as it is the commonest cause of death in those aged under 40 years in the developed world. The treatments that are used in patients with severe head injury are largely supportive. Studies in animals have shown us that inflammation in the brain after it is injured can make the injury worse. This study will look at the levels of inflammatory molecules, called cytokines, in the brain and see if blocking these molecules? action reduces the damage to nerve cells.
The study will be carried out in the Division of Neurosurgery in the University of Cambridge. We will use a monitoring technique called microdialysis to enable us to measure the levels of cytokines in the brains of patients with severe head injuries. We will go on to see if the levels of these cytokines are associated with activation of inflammatory cells within the brain called microglia. 
We will also test to see whether these cytokines are toxic to human nerve cells (neurons) when these cells are grown outside the body.</gtr:abstractText><gtr:technicalSummary>Traumatic Brain Injury (head injury, TBI) is a common cause of death and disability in both the developed and developing world. The potentially damaging role of cerebral inflammation following TBI has been demonstrated in many animal models. However, this data is yet to be replicated in humans. In particular, the interleukin-1 family of cytokines has been heavily implicated in potentiating neuronal injury. Our aim is to characterise the cytokine response following human TBI using cerebral microdialysis, a technique for sampling the brain extracellular space.
The first objective will be to develop a robust microdialysis methodology for the recovery of cytokines. Initially, this has taken the form of in vitro testing of the microdialysis catheters already employed in clinical use to determine the relative recovery for each cytokine of interest and to investigate the effect of albumin in the perfusate on relative recovery. The two types of perfusate will then be compared directly in vivo using paired catheters in the same patient.
The microdialysis methodology from these initial studies will be used in an observational study of the temporal course of cytokine expression following human TBI focusing on the following cytokines IL-1?, IL-1?, IL-1receptor antagonist, IL-6, IL-8 and TNF-?. 
The next objective will be to carry out a randomised interventional study using IL-1receptor antagonist in human patients following severe TBI. The primary outcome will be safety however we will also incorporate cerebral microdialysis to determine whether the drug crosses the blood brain barrier and whether it alters the pattern of cytokine expression.
We also intend to elucidate the relationship between cytokine expression and microglial activation using a combined PET-microdialysis study, using the PK11195 ligand. It is hypothesised that activated microglia are the source of cytokine expression following trauma.
Finally, we will test the putative neurotoxic effects of the microdialysate recovered from the human brain following TBI on human neuronal cell culture. Our objective is to develop an in vitro neurotoxicity assay that can then be utilised to investigate which, if any, of the components of the microdialysate is toxic to neurons. 
Taken together these studies will further our understanding of the molecular mediators of injury following human TBI by replicating and furthering many of the findings from animal models. In addition, attenuating the inflammatory response following TBI may provide a novel therapeutic approach for the treatment of human TBI.</gtr:technicalSummary><gtr:fund><gtr:end>2012-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>200782</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>360101</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>Mechanism of action of Tranexamic Acid in isolated traumatic brain injury</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>2AFB7810-A0ED-453A-933A-478B0E87374E</gtr:id><gtr:outcomeId>58c17e1a418dc2.18659332</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal College of Surgeons Pump Priming Award</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>Royal College of Surgeons of England</gtr:fundingOrg><gtr:fundingRef>Personal Award</gtr:fundingRef><gtr:id>4D48088D-249D-4272-B24C-95CAA50B9EBD</gtr:id><gtr:outcomeId>58c17e772019d5.89721434</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>408068</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant: 'Cerebral Energy Metabolism in Injured and Uninjured Brain'</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7AF6A479-9742-4AEB-BCAB-49980CC509E4</gtr:id><gtr:outcomeId>gHyZKdt4BeT0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>914FB1EA-5311-41EA-AD34-9F34CC4E770B</gtr:id><gtr:title>Sex and the cytokines: are there fundamental differences in response to brain injury?</gtr:title><gtr:parentPublicationTitle>Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-396X</gtr:issn><gtr:outcomeId>pm_13313_23_21694657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>007363F0-E638-4EBB-941F-B49E03BBD3CC</gtr:id><gtr:title>Glycolysis and the pentose phosphate pathway after human traumatic brain injury: microdialysis studies using 1,2-(13)C2 glucose.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>54576840f34cc3.00081342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62A8EB83-8BE9-4744-9A48-51425C812FD5</gtr:id><gtr:title>Noninvasive monitoring of cerebrovascular reactivity with near infrared spectroscopy in head-injured patients.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c9cbaea1bd63c1fa06b432d81d3e5e7"><gtr:id>7c9cbaea1bd63c1fa06b432d81d3e5e7</gtr:id><gtr:otherNames>Zweifel C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>thj3TDdpWdu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3224CFF2-71E1-4F2C-9C07-418C28B710D4</gtr:id><gtr:title>Hierarchical log linear analysis of admission blood parameters and clinical outcome following traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>mbMwN99TTTj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B48E2FAA-9BB6-46D8-9068-DE46588DC5EF</gtr:id><gtr:title>Fixed, dilated pupils following traumatic brain injury: historical perspectives, causes and ophthalmological sequelae.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica. Supplement</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-1419</gtr:issn><gtr:outcomeId>pm_13313_23_22327711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6F1E52B-951F-41DF-9817-D0D4B3838110</gtr:id><gtr:title>Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Progress in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0301-0082</gtr:issn><gtr:outcomeId>pm_13313_23_21939729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5477F82E-1B51-4E44-BB53-EA9037D07DE5</gtr:id><gtr:title>Traumatic brain injury in England and Wales: prospective audit of epidemiology, complications and standardised mortality.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9840fd94b2f1df7980e154fd24bf3379"><gtr:id>9840fd94b2f1df7980e154fd24bf3379</gtr:id><gtr:otherNames>Lawrence T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>58c17a6b0f0682.09023359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AECE3F0-30B9-4100-A5ED-07507B0A3768</gtr:id><gtr:title>Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings.</gtr:title><gtr:parentPublicationTitle>Metabolic brain disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-7490</gtr:issn><gtr:outcomeId>doi_55f984984f6adaaa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>850C07D7-D50A-460C-8F33-FFBB62EB18BF</gtr:id><gtr:title>What constitutes Clinical Equipoise?</gtr:title><gtr:parentPublicationTitle>British journal of neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-8697</gtr:issn><gtr:outcomeId>pm_13313_13_19718548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B2C69C7-6BCB-4BFF-8F27-F7E8B622D92C</gtr:id><gtr:title>Principal component analysis of the cytokine and chemokine response to human traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13313_23_22745809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EEAD10D-C154-4FEB-BCBE-FA28826187BA</gtr:id><gtr:title>Systemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established?</gtr:title><gtr:parentPublicationTitle>Frontiers in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d61a838a3baffbe1120c9291178df3c"><gtr:id>7d61a838a3baffbe1120c9291178df3c</gtr:id><gtr:otherNames>Carpenter KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-2295</gtr:issn><gtr:outcomeId>585d67ec325323.30648406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2138863B-FC1B-488C-82F3-91C368DDDD0E</gtr:id><gtr:title>Lactate uptake by the injured human brain: evidence from an arteriovenous gradient and cerebral microdialysis study.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>pm_13313_23_23968221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>579D2183-4B6A-4263-935B-2946E4AA6147</gtr:id><gtr:title>Cerebral tuberculoma and magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society of Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0141-0768</gtr:issn><gtr:outcomeId>pm_13313_23_21725096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA2BCF89-19BF-460E-9EBE-774FE1C268C2</gtr:id><gtr:title>Is cerebral microdialysis a clinical tool?</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>pm_13313_23_23263482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63D3C971-31C2-4408-992F-D36FB54A03AE</gtr:id><gtr:title>Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>585d67df765dc8.65139382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6009C10F-00F5-46DC-8761-21EFFA6013CE</gtr:id><gtr:title>Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>54576889c1d956.54418853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18F00078-5E2D-4EDB-80A0-FB01C637E180</gtr:id><gtr:title>Monitoring the Neuroinflammatory Response Following Acute Brain Injury.</gtr:title><gtr:parentPublicationTitle>Frontiers in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/906cbce1b4a30d977e9b48a0c818f048"><gtr:id>906cbce1b4a30d977e9b48a0c818f048</gtr:id><gtr:otherNames>Thelin EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-2295</gtr:issn><gtr:outcomeId>5a6146482c6955.66835966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D03C4962-9C3E-43E2-8916-19AC5987218C</gtr:id><gtr:title>Response to letter &amp;quot;Lactate uptake against a concentration gradient: misinterpretation of analytical imprecision&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40168690ad56cf8307addaea34e175cf"><gtr:id>40168690ad56cf8307addaea34e175cf</gtr:id><gtr:otherNames>Jalloh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>545768414e3799.89376405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8D68A80-321F-4E73-BC99-70D2B11B409C</gtr:id><gtr:title>Cerebrospinal Fluid and Microdialysis Cytokines in Severe Traumatic Brain Injury: A Scoping Systematic Review.</gtr:title><gtr:parentPublicationTitle>Frontiers in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad96a1bfa00b6607c82b620ce1837a5b"><gtr:id>ad96a1bfa00b6607c82b620ce1837a5b</gtr:id><gtr:otherNames>Zeiler FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-2295</gtr:issn><gtr:outcomeId>5a61480e891ef1.87721790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48C8641C-7873-4485-AB47-4A285243D4DB</gtr:id><gtr:title>Cerebrospinal Fluid and Microdialysis Cytokines in Aneurysmal Subarachnoid Hemorrhage: A Scoping Systematic Review.</gtr:title><gtr:parentPublicationTitle>Frontiers in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad96a1bfa00b6607c82b620ce1837a5b"><gtr:id>ad96a1bfa00b6607c82b620ce1837a5b</gtr:id><gtr:otherNames>Zeiler FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-2295</gtr:issn><gtr:outcomeId>5a614dd0092df3.66654902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42CBAE5B-7998-4234-BFA9-148B826687B4</gtr:id><gtr:title>Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>c1mNh5E1isz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>533AD9AD-1B76-4BC2-BA8D-B4CC818FF3A2</gtr:id><gtr:title>Spinal intradural haemorrhage in a patient with Wegener's Granulomatosis.</gtr:title><gtr:parentPublicationTitle>Clinical neurology and neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de49ceeeba6bbdb0d7189a130938fe75"><gtr:id>de49ceeeba6bbdb0d7189a130938fe75</gtr:id><gtr:otherNames>Guilfoyle MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-8467</gtr:issn><gtr:outcomeId>f322gymHV5d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2B11099-4C47-4A38-BDF0-9665794224DA</gtr:id><gtr:title>Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development.</gtr:title><gtr:parentPublicationTitle>The AAPS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/906cbce1b4a30d977e9b48a0c818f048"><gtr:id>906cbce1b4a30d977e9b48a0c818f048</gtr:id><gtr:otherNames>Thelin EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1550-7416</gtr:issn><gtr:outcomeId>58c17cb73263e3.58715498</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9C1C2DD-9F60-4683-97C6-A80F4E759665</gtr:id><gtr:title>A systematic review of cerebral microdialysis and outcomes in TBI: relationships to patient functional outcome, neurophysiologic measures, and tissue outcome.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad96a1bfa00b6607c82b620ce1837a5b"><gtr:id>ad96a1bfa00b6607c82b620ce1837a5b</gtr:id><gtr:otherNames>Zeiler FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>5a614649597e83.63018826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8ABCD97-9565-4A68-B862-DAC4296A3E9E</gtr:id><gtr:title>Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications.</gtr:title><gtr:parentPublicationTitle>Journal of pharmacokinetics and pharmacodynamics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0482ab6c0e91e5b3cbf602ea6fad1642"><gtr:id>0482ab6c0e91e5b3cbf602ea6fad1642</gtr:id><gtr:otherNames>Shannon RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-567X</gtr:issn><gtr:outcomeId>pm_13313_23_23468415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0F3AB02-5FD2-443C-97A5-DF5EE5EF4DE8</gtr:id><gtr:title>Elucidating Pro-Inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/906cbce1b4a30d977e9b48a0c818f048"><gtr:id>906cbce1b4a30d977e9b48a0c818f048</gtr:id><gtr:otherNames>Thelin EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>5a61482cd47839.69507165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05188EE9-E3F3-4809-8084-E6368BA40B46</gtr:id><gtr:title>The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0e0d34e432642960330778f7f6ba3cc"><gtr:id>a0e0d34e432642960330778f7f6ba3cc</gtr:id><gtr:otherNames>Budohoski KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5457684127df16.93924923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC269396-3EB8-4C44-8DC4-1F36BF3F2383</gtr:id><gtr:title>The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d376fc1cca4a25e96031212a61c4522c"><gtr:id>d376fc1cca4a25e96031212a61c4522c</gtr:id><gtr:otherNames>Helmy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>MzDTUSBPkps</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802251</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>